328 related articles for article (PubMed ID: 23716300)
21. Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
Baldwin SL; Reese VA; Larsen SE; Beebe E; Guderian J; Orr MT; Fox CB; Reed SG; Coler RN
PLoS One; 2021; 16(3):e0247990. PubMed ID: 33705411
[TBL] [Abstract][Full Text] [Related]
22. The importance of adjuvant formulation in the development of a tuberculosis vaccine.
Baldwin SL; Bertholet S; Reese VA; Ching LK; Reed SG; Coler RN
J Immunol; 2012 Mar; 188(5):2189-97. PubMed ID: 22291184
[TBL] [Abstract][Full Text] [Related]
23. MyD88 signaling inhibits protective immunity to the gastrointestinal helminth parasite Heligmosomoides polygyrus.
Reynolds LA; Harcus Y; Smith KA; Webb LM; Hewitson JP; Ross EA; Brown S; Uematsu S; Akira S; Gray D; Gray M; MacDonald AS; Cunningham AF; Maizels RM
J Immunol; 2014 Sep; 193(6):2984-93. PubMed ID: 25114104
[TBL] [Abstract][Full Text] [Related]
24. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.
Embry CA; Franchi L; Nuñez G; Mitchell TC
Sci Signal; 2011 May; 4(171):ra28. PubMed ID: 21540455
[TBL] [Abstract][Full Text] [Related]
26. IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.
Desbien AL; Dubois Cauwelaert N; Reed SJ; Bailor HR; Liang H; Carter D; Duthie MS; Fox CB; Reed SG; Orr MT
J Immunol; 2016 Dec; 197(11):4351-4359. PubMed ID: 27794001
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Cho SN; Coler RN; Reed SG; Shin SJ
Vaccine; 2016 Apr; 34(19):2179-87. PubMed ID: 27005808
[TBL] [Abstract][Full Text] [Related]
28. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
Mata-Haro V; Cekic C; Martin M; Chilton PM; Casella CR; Mitchell TC
Science; 2007 Jun; 316(5831):1628-32. PubMed ID: 17569868
[TBL] [Abstract][Full Text] [Related]
29. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
30. Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.
Bowen WS; Minns LA; Johnson DA; Mitchell TC; Hutton MM; Evans JT
Sci Signal; 2012 Feb; 5(211):ra13. PubMed ID: 22337809
[TBL] [Abstract][Full Text] [Related]
31. The combination of maltose-binding protein and BCG-induced Th1 activation is involved in TLR2/9-mediated upregulation of MyD88-TRAF6 and TLR4-mediated downregulation of TRIF-TRAF3.
Liu G; Zhai X; Zhou H; Yang X; Zhang N; Tai G; Ni W
Cell Immunol; 2018 Mar; 325():56-63. PubMed ID: 29452695
[TBL] [Abstract][Full Text] [Related]
32. Differential requirements of MyD88 and TRIF pathways in TLR4-mediated immune responses in murine B cells.
Yanagibashi T; Nagai Y; Watanabe Y; Ikutani M; Hirai Y; Takatsu K
Immunol Lett; 2015 Jan; 163(1):22-31. PubMed ID: 25448706
[TBL] [Abstract][Full Text] [Related]
33. Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus.
Buchholz BM; Billiar TR; Bauer AJ
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G531-8. PubMed ID: 20508155
[TBL] [Abstract][Full Text] [Related]
34. Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.
Duthie MS; Coler RN; Laurance JD; Sampaio LH; Oliveira RM; Sousa AL; Stefani MM; Maeda Y; Matsuoka M; Makino M; Reed SG
Infect Immun; 2014 Sep; 82(9):3979-85. PubMed ID: 25024362
[TBL] [Abstract][Full Text] [Related]
35. B cell-intrinsic MyD88 signaling controls IFN-γ-mediated early IgG2c class switching in mice in response to a particulate adjuvant.
Lee MSJ; Natsume-Kitatani Y; Temizoz B; Fujita Y; Konishi A; Matsuda K; Igari Y; Tsukui T; Kobiyama K; Kuroda E; Onishi M; Marichal T; Ise W; Inoue T; Kurosaki T; Mizuguchi K; Akira S; Ishii KJ; Coban C
Eur J Immunol; 2019 Sep; 49(9):1433-1440. PubMed ID: 31087643
[TBL] [Abstract][Full Text] [Related]
36. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.
Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B
Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061
[TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF.
McAleer JP; Rossi RJ; Vella AT
J Immunol; 2009 May; 182(9):5322-30. PubMed ID: 19380779
[TBL] [Abstract][Full Text] [Related]
38.
Kim WS; Jung ID; Kim JS; Kim HM; Kwon KW; Park YM; Shin SJ
Front Cell Infect Microbiol; 2018; 8():95. PubMed ID: 29637049
[No Abstract] [Full Text] [Related]
39. Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
Orr MT; Beebe EA; Hudson TE; Argilla D; Huang PW; Reese VA; Fox CB; Reed SG; Coler RN
Vaccine; 2015 Nov; 33(48):6570-8. PubMed ID: 26541135
[TBL] [Abstract][Full Text] [Related]
40. Molecular and cellular response profiles induced by the TLR4 agonist-based adjuvant Glucopyranosyl Lipid A.
Lambert SL; Yang CF; Liu Z; Sweetwood R; Zhao J; Cheng L; Jin H; Woo J
PLoS One; 2012; 7(12):e51618. PubMed ID: 23284726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
